WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

Allergan plc confirms discussions regarding potential business combination transaction with Pfizer Inc.

Details
Financial
29 October 2015
Allergan plc today confirmed that it has been approached by Pfizer Inc. and is in preliminary friendly discussions regarding a potential business combination transaction. Allergan stated that no agreement has been reached and there can be no certainty that these discussions will lead to a transaction, or as to the terms on which a transaction, if any, might be agreed.
Read more ...

AstraZeneca rejects final proposal from Pfizer

Details
Financial
19 May 2014
The Board of AstraZeneca PLC notes the announcement by Pfizer Inc. of its final proposal to combine the two companies. Leif Johansson, Chairman of AstraZeneca mentioned that the final proposal is a minor improvement which continues to fall short of the Board's view of value and has been rejected.
Read more ...

Pfizer announcement and AstraZeneca statement

Details
Financial
13 May 2014
Pfizer wishes to enter into discussions with AstraZeneca regarding a potential combination of the two companies and is "disappointed at the lack of engagement by the AstraZeneca Board". The Board of AstraZeneca notes the announcement made by Pfizer and states that the "announcement contains no new proposal nor substantive new information."
Read more ...

Forest Laboratories to Acquire Clinical Data, Inc.

Details
Financial
22 February 2011
Forest LaboratoriesForest Laboratories, Inc. (Forest) (NYSE: FRX) and Clinical Data, Inc. (Clinical Data) (NASDAQ: CLDA) have entered into a definitive merger agreement pursuant to which Forest will acquire Clinical Data, a specialty pharmaceutical company focused on the development of first-in-class and best-in-category therapeutics,
Read more ...

Convergence Pharmaceuticals Successfully Launched out of GSK to Focus on Novel High Value Analgesics

Details
Financial
07 October 2010
Convergence Pharmaceuticals Ltd, a new company focused on the development of novel and high value analgesic medicines, was officially launched and has successfully raised $35.4 million (£22.4 million) in Series A financing from a syndicate of leading European and US life science investors. Convergence Pharmaceuticals is an independent biotechnology company that has acquired clinical assets from GlaxoSmithKline ("GSK").
Read more ...

Mylan to Acquire Bioniche Pharma Global Injectable Pharmaceuticals Business

Details
Financial
16 July 2010
Mylan Inc. (Nasdaq: MYL) has announced plans to acquire Bioniche Pharma Holdings Limited, a privately held, global injectable pharmaceutical company for $550 million in cash.
Read more ...

Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc.

Details
Financial
20 May 2010
Astellas Pharma Inc.Astellas Pharma Inc. (TSE: 4503), a global pharmaceutical company, and OSI Pharmaceuticals, Inc. (Nasdaq: OSIP), a biotechnology company primarily focused on the discovery, development and commercialization of molecular targeted therapies addressing medical needs in oncology, diabetes and obesity, have entered into a definitive merger agreement under which Astellas will acquire OSI.
Read more ...

More Pharma News ...

  1. ratiopharm to become the hub for Teva's European growth strategy
  2. Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results
  3. Johnson & Johnson Announces Definitive Agreement to Acquire Omrix
  4. Alpharma Responds To Unsolicited Proposal By King Pharmaceuticals, Inc.
  5. King Proposes Acquisition of Alpharma for $33 Per Share in Cash
  6. Teva Reports Second Quarter 2008 Results - Record Quarterly Sales of $2,823 Million
  7. Grindeks profit reaches 5 million lats in the first half of 2008
  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next
  • End

Business & Industry

  • Roche's subcutaneous formulation of Tecentriq demonstrates positive Phase III results
  • Bayer Consumer Health leaders propose new principles for science-led self-care
  • GSK signs agreement to support pandemic preparedness in Europe
  • Pfizer and BioNTech advance COVID-19 vaccine strategy with study start of next-generation vaccine candidate based on enhanced spike protein design
  • AstraZeneca to acquire TeneoTwo and its clinical-stage T-cell engager

Research & Development

  • Treating cancer by sticking cells in place
  • Vitamin K prevents cell death: a new function for a long-known molecule
  • Disparities in United States COVID-19 vaccine distribution
  • New needle-free nasal vaccine shows promise for COVID-19
  • Scientists develop new biomimetic formulation for treating glioblastoma
  • SARS-CoV-2 hijacks nanotubes between neurons to infect them
  • Demonstration of a potent, universal coronavirus monoclonal antibody therapy for all COVID-19 variants

Conferences & Events

  • New approach to treatment of deadly kidney cancer
  • SAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference
  • Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
  • SMi's 22nd Annual Pain Therapeutics Conference
  • SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
  • SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
  • SMi's 3rd Annual AI in Drug Discovery Conference

Regulatory Affairs

  • FDA approves first systemic treatment for alopecia areata
  • FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
  • FDA limits use of Janssen COVID-19 vaccine to certain individuals
  • EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
  • FDA approves first generic of Symbicort to treat asthma and COPD
  1. You are here:  
  2. Home
  3. Financial

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2022. All Rights Reserved.